Literature DB >> 30554800

Allostasis and the Clinical Manifestations of Mild to Moderate Chronic Hyponatremia: No Good Adaptation Goes Unpunished.

Ignacio Portales-Castillo1, Richard H Sterns2.   

Abstract

When homeostatic regulatory systems are unable to maintain a normal serum sodium concentration, the organism must adapt to demands of a disordered internal environment, a process known as "allostasis." Human cells respond to osmotic stress created by an abnormal serum sodium level with the same adaptations used by invertebrate organisms that do not regulate body fluid osmolality. To avoid intolerable changes in their volume, cells export organic osmolytes when exposed to a low serum sodium concentration and accumulate these intracellular solutes when serum sodium concentration increases. The brain's adaptation to severe hyponatremia (serum sodium < 120 mEq/L) has been studied extensively. However, adaptive responses occur with less severe hyponatremia and other tissues are affected; the consequences of these adaptations are incompletely understood. Recent epidemiologic studies have shown that mild (sodium, 130-135 mEq/L) and moderate (sodium, 121-129 mEq/L) chronic hyponatremia, long thought to be inconsequential, is associated with adverse outcomes. Adaptations of the heart, bone, brain, and (possibly) immune system to sustained mild to moderate hyponatremia may adversely affect their function and potentially the organism's survival. This review explores what is known about the consequences of mild to moderate chronic hyponatremia and the potential benefits of treating this condition.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  Allostasis; chronic; falls; fractures; gait; hyponatremia; mortality; neurocognitive; osmotic stress; osteoporosis; reversibility; review; serum sodium; stones; tolvaptan; vasopressin receptor antagonist

Mesh:

Year:  2018        PMID: 30554800     DOI: 10.1053/j.ajkd.2018.10.004

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  5 in total

1.  A Randomized Trial of Empagliflozin to Increase Plasma Sodium Levels in Patients with the Syndrome of Inappropriate Antidiuresis.

Authors:  Julie Refardt; Cornelia Imber; Clara O Sailer; Nica Jeanloz; Laura Potasso; Alexander Kutz; Andrea Widmer; Sandrine A Urwyler; Fahim Ebrahimi; Deborah R Vogt; Bettina Winzeler; Mirjam Christ-Crain
Journal:  J Am Soc Nephrol       Date:  2020-02-04       Impact factor: 10.121

2.  Association of early hyponatremia and the development of acute kidney injury in critically ill children.

Authors:  Cassandra L Formeck; Nalyn Siripong; Emily L Joyce; Juan C Ayus; John A Kellum; Michael L Moritz
Journal:  Pediatr Nephrol       Date:  2022-02-24       Impact factor: 3.651

Review 3.  Magnesium, Calcium, Potassium, Sodium, Phosphorus, Selenium, Zinc, and Chromium Levels in Alcohol Use Disorder: A Review.

Authors:  Jacek Baj; Wojciech Flieger; Grzegorz Teresiński; Grzegorz Buszewicz; Ryszard Sitarz; Alicja Forma; Kaja Karakuła; Ryszard Maciejewski
Journal:  J Clin Med       Date:  2020-06-18       Impact factor: 4.241

4.  Etiology Analysis and Diagnosis and Treatment Strategy of Traumatic Brain Injury Complicated With Hyponatremia.

Authors:  Jianhua Zhang; Wensheng Dong; Xianghong Dou; Jinjin Wang; Peng Yin; Hui Shi
Journal:  Front Surg       Date:  2022-02-21

5.  Risk of Adverse Clinical Outcomes in Hyponatremic Adult Patients Hospitalized for Acute Medical Conditions: A Population-Based Cohort Study.

Authors:  Alexander Kutz; Fahim Ebrahimi; Soheila Aghlmandi; Ulrich Wagner; Miluska Bromley; Ben Illigens; Timo Siepmann; Philipp Schuetz; Beat Mueller; Mirjam Christ-Crain
Journal:  J Clin Endocrinol Metab       Date:  2020-11-01       Impact factor: 5.958

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.